These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 26273599

  • 1. Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients.
    Wei Y, Sun X, Hua M, Tan W, Wang F, Zhang M.
    Biomed Res Int; 2015; 2015():214683. PubMed ID: 26273599
    [Abstract] [Full Text] [Related]

  • 2. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Wang XT, Li P, Xu TS, Ding R, Zhang X, Bi LQ.
    Cell Mol Biol (Noisy-le-grand); 2016 Oct 31; 62(12):44-50. PubMed ID: 27894399
    [Abstract] [Full Text] [Related]

  • 3. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB.
    Arthritis Rheum; 2004 Dec 31; 50(12):3831-43. PubMed ID: 15593184
    [Abstract] [Full Text] [Related]

  • 4. T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro.
    Du F, Lü LJ, Teng JL, Shen N, Ye P, Bao CD.
    Int Immunopharmacol; 2012 May 31; 13(1):54-60. PubMed ID: 22446297
    [Abstract] [Full Text] [Related]

  • 5. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT.
    Arthritis Rheum; 2008 Aug 31; 58(8):2397-408. PubMed ID: 18668542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
    Lee HY, Jeon HS, Song EK, Han MK, Park SI, Lee SI, Yun HJ, Kim JR, Kim JS, Lee YC, Kim SI, Kim HR, Choi JY, Kang I, Kim HY, Yoo WH.
    Arthritis Rheum; 2006 Jun 31; 54(6):1747-58. PubMed ID: 16736517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
    Nakano K, Okada Y, Saito K, Tanaka Y.
    Arthritis Rheum; 2004 Aug 31; 50(8):2450-8. PubMed ID: 15334457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.